The activation of the mu-opioid receptor promoted head and neck squamous cell carcinoma growth in vitro and in vivo experiments, increasing the proliferation and migration of tumor cells (FaDu, MDA6868Tu) [179]. This evidence concerns the gene OPRM1 and head and neck squamous cell carcinoma.